Variables | Total patients (n = 3,179) | Survivors (n = 1,127) | Non-survivors (n = 2,052) | P value |
---|---|---|---|---|
Demographic data | Â | Â | Â | Â |
 Age (years) | 71(14) | 67(15) | 73(14) | < 0.001 |
 Sex,n(%) |  |  |  | 0.505 |
  Male | 1,481(46.60) | 526(35.50) | 955(64.50) |  |
  Female | 1,698(53.40) | 601(35.40) | 1,097(64.60) |  |
 Race,n(%) |  |  |  | < 0.001 |
  Mexican American | 445(14.00) | 148(33.30) | 307(66.70) |  |
  Non-Hispanic White | 1,453(45.70) | 388(26.70) | 1,065(73.30) |  |
  Non-Hispanic Black | 988(31.12) | 399(40.43) | 589(59.61) |  |
  Other Race | 273(9.21) | 171(62.82) | 102(37.23) |  |
 BMI (kg/m2) | 30.01(8.17) | 31.37(8.99) | 29.13(7.65) | < 0.001 |
 Heavy drinking,n(%) | 223(70.00) | 129(11.40) | 94(4.60) | < 0.001 |
 Heavy smoking,n(%) | 573(18.00) | 38(3.37) | 535(26.07) | 0.005 |
 Hypertension,n(%) | 2,429(76.40) | 927(82.30) | 1,052(73.20) | < 0.001 |
 CVD,n(%) |  |  |  | < 0.001 |
  Yes | 1,189(37.40) | 360(30.20) | 829(69.80) |  |
  No | 1,990(62.60) | 767(38.50) | 1,284(61.50) |  |
Laboratory data | Â | Â | Â | Â |
 Magnesium intake (mg) | 224(133) | 224(134) | 224(133) | 0.583 |
 eGFR (mL/min/1.73m2) | 49.8188(17.03) | 52.4436(16.04) | 48.1831(17.54) | < 0.001 |
 eGDR (mg/kg/min) | 4.4692(2.24) | 4.1123(2.34) | 4.5683(2.12) | < 0.001 |
 TyG | 6.8218(0.88) | 6.8555(0.77) | 7.0189(0.91) | < 0.001 |
 HbA1c (%,mmol/mol) | 6.5(48) | 6.6(49) | 6.4(46) | < 0.001 |
 Blood glucose control,n(%) |  |  |  | 0.021 |
  Good | 1,869(58.80) | 633(56.20) | 810(39.50) |  |
  Poor | 1,310(41.20) | 494(43.80) | 1,242(60.50) |  |
 TC (mmol/L) | 4.7580(1.78) | 4.4740(1.49) | 5.0757(1.87) | < 0.001 |
 TG (mmol/L) | 1.4790(0.99) | 1.4450(0.97) | 1.4925(1.03) | < 0.001 |
 BUN (mmol/L) | 7.32(3.93) | 7.140(3.92) | 7.500(4.29) | < 0.001 |
 UA (umol/L) | 386.65(136.80) | 392.6(124.90) | 386.6(143.45) | 0.879 |
 HDL-C (mmol/L) | 1.22(0.50) | 1.24(0.52) | 1.22(0.49) | 0.405 |
 LDL (mmol/L) | 2.7410(1.50) | 2.483(1.24) | 3.00(1.60) | < 0.001 |
 FBG (mg/dL) | 136.4(51.86) | 133(49.75) | 138(55.10) | 0.04 |
 Serum phosphorus (mmol/L) | 1.113(0.26) | 1.13(0.20) | 1.13(0.26) | < 0.001 |
 Serum total calcium (mg/dL) | 9.30(0.50) | 9.30(0.50) | 9.30(0.50) | 0.993 |
 CMI | 0.92(1.17) | 0.89(1.05) | 0.97(1.22) | < 0.001 |
 AIP | 4.08(1.68) | 3.76(1.50) | 4.34(1.74) | < 0.001 |
Medications | Â | Â | Â | Â |
 Statins use,n(%) | 213(6.70) | 117(10.40) | 96(4.60) | < 0.001 |
 Insulin use,n(%) | 92(2.90) | 32(2.80) | 60(2.90) | 0.913 |
 Metformin use,n(%) | 28(0.90) | 20(1.80) | 8(0.40) | < 0.001 |
 Diuretic use,n(%) | 16(0.50) | 10(0.90) | 6(0.30) | 0.071 |
 PPI use,n(%) | 207(6.50) | 52(4.60) | 155(7.60) | < 0.001 |
 MDS,n(%) |  |  |  | < 0.001 |
  0 | 89(2.80) | 54(4.80) | 35(1.70) |  |
  1 | 212(6.70) | 94(8.50) | 116(5.70) |  |
  2 | 2,509(78.90) | 834(74.00) | 1,675(81.60) |  |
  ≥ 3 | 369(12.20) | 143(12.70) | 226(11.60) |  |